Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on February 27, 2026

Feb. 27, 2026

Atos named a Leader in ISG Provider Lens™ 2025 for Cybersecurity – Services and Solutions in the United States

GlobeNewswire

Feb. 27, 2026

Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting

GlobeNewswire

Feb. 27, 2026

The Standard Process Brand Evolution Elevates Awareness of Whole Food Nutrition

GlobeNewswire

Feb. 27, 2026

Your Kidneys Count: American Kidney Fund Urges Americans to Protect Their Health this Kidney Month

GlobeNewswire

Feb. 27, 2026

Global Proteomics Services Market to Reach USD 16.46 Billion by 2030 | MarketsandMarkets™

GlobeNewswire

Feb. 27, 2026

New Study Finds Half of Americans Don’t Know You Can Screen for Colorectal Cancer at Home

GlobeNewswire

Feb. 27, 2026

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

GlobeNewswire

Feb. 27, 2026

ESO Wave Convenes Emergency Services and Healthcare Leaders To Advance Data-Driven Outcomes

GlobeNewswire

Feb. 27, 2026

Exceptional Clinical Trial Volunteers Presented National Citizen Scientist Awards for Research Efforts

GlobeNewswire

Feb. 27, 2026

AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering

GlobeNewswire

Feb. 27, 2026

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry

GlobeNewswire

Feb. 27, 2026

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

GlobeNewswire

Feb. 27, 2026

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders

GlobeNewswire

Feb. 27, 2026

ZUSDURI™ Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC

GlobeNewswire

Feb. 27, 2026

CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates

GlobeNewswire

Feb. 27, 2026

Certara to Participate in Upcoming Investor Conferences

GlobeNewswire

Feb. 27, 2026

RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum

GlobeNewswire

Feb. 27, 2026

MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations

GlobeNewswire

Feb. 27, 2026

OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

GlobeNewswire

Feb. 27, 2026

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire